Use of a single anti-Xa calibration curve is adequate for monitoring enoxaparin and tinzaparin levels in children

Thrombosis Research

Volumn 122, Issue 6, 2008, Pages 867-869

  Robertson, Jeremy D ^a   Brandao, Leonardo ^a   Williams, Suzan ^a   Ing, Cindy ^a   Chan, Anthony K C ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10A; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; TINZAPARIN;

ADOLESCENT; BLEEDING; CALIBRATION; CONTROLLED STUDY; FEMALE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD;

ADOLESCENT; ANTICOAGULANTS; CALIBRATION; CHILD; CHILD, PRESCHOOL; DRUG MONITORING; ENOXAPARIN; FACTOR XA; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INFANT; INFANT, NEWBORN; MALE; PROSPECTIVE STUDIES;

EID: 52049127027     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2008.05.012     Document Type: Letter

References (7)

1. Nowak-Gottl U., Bidlingmaier C., Krumpel A., Gottl L., and Kenet G. Pharmacokinetics, efficacy, and safety of LMWHs in venous thrombosis and stroke in neonates, infants and children. Br J Pharmacol 153 (2008) 1120-1127
2. Bounameaux H., and De Moerloose P. Is laboratory monitoring of low molecular weight heparin necessary?. No. J Thromb Haemost 2 (2004) 551-554
3. Kuhle S., Massicotte P., Dinyari M., Vegh P., Mitchell D., Marzinotto V., et al. Dose-finding and pharmacokinetics of therapeutic doses of tinzaparin in pediatric patients with thromboembolic events. Thromb Haemost 94 (2005) 1164-1171
4. Hirsh J., and Raschke R. Heparin and low-molecular-weight heparin. The Seventh ACCP Conference on antithrombotic and thrombolytic therapy. Chest 126 3 Suppl (2004) 188S-203S
5. Baglin T., Barrowcliffe T.W., Cohen A., and Greaves M. Guidelines on the use and monitoring of heparin. Br J Haematol 133 (2006) 19-34
6. McGlasson D.L. Using a single calibration curve with the anti-xa chromogenic assay for monitoring heparin anticoagulation. Lab Med 36 (2005) 1-3
7. Greaves M. Limitations of the laboratory monitoring of heparin therapy. Thromb Haemost 87 (2002) 163-164